Neuphoria Therapeutics Inc. Held Annual Shareholder Meeting
I'm PortAI, I can summarize articles.
Neuphoria Therapeutics Inc. held its Annual Shareholder Meeting on December 12, 2025. Shareholders elected Peter Miles Davies and David Wilson as Class I directors, and ratified Wolf & Company P.C. as the independent accounting firm for the fiscal year ending June 30, 2026. Nominees Stephen Doberstein and Kimberly Smith were not elected to the board. This information was published via EDGAR by Neuphoria Therapeutics Inc.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments